90726726 - MYOTRUVI

Information

• Trademark
• 90726726

• Source

• Serial Number

  90726726

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations

• Filing Date

  May 21, 2021
  3 years ago

• Transaction Date

  March 29, 2024
  2 months ago

• Status Date

  March 28, 2024
  2 months ago

• Published for Opposition Date

  August 30, 2022
  a year ago

• Location Date

  October 25, 2022
  a year ago

• Status Code

  732

• Current Location

  INTENT TO USE SECTION

  Employee Name

  BECHHOFER, YOCHEVED D

• Attorney Name

  Maury M. Tepper, III

  Law Office Assigned Location Code

  M50

• Owners

  • SAREPTA THERAPEUTICS, INC.

Case File Statements

• GS0051: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products, namely, pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases

Case File Event Statements

• 3/29/2024 - 2 months ago

  26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 3/28/2024 - 2 months ago

  25 - SOU EXTENSION 3 GRANTED Type: EX3G

• 3/28/2024 - 2 months ago

  24 - SOU EXTENSION 3 FILED Type: EXT3

• 3/28/2024 - 2 months ago

  23 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 10/12/2023 - 7 months ago

  22 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 10/10/2023 - 7 months ago

  21 - SOU EXTENSION 2 GRANTED Type: EX2G

• 10/10/2023 - 7 months ago

  20 - SOU EXTENSION 2 FILED Type: EXT2

• 10/10/2023 - 7 months ago

  19 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 3/30/2023 - a year ago

  18 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 3/28/2023 - a year ago

  17 - SOU EXTENSION 1 GRANTED Type: EX1G

• 3/28/2023 - a year ago

  16 - SOU EXTENSION 1 FILED Type: EXT1

• 3/28/2023 - a year ago

  15 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 10/25/2022 - a year ago

  14 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 8/30/2022 - a year ago

  13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 8/30/2022 - a year ago

  12 - PUBLISHED FOR OPPOSITION Type: PUBO

• 8/10/2022 - a year ago

  11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 7/26/2022 - a year ago

  10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 7/25/2022 - a year ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/25/2022 - a year ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 7/25/2022 - a year ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 2/3/2022 - 2 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 2/3/2022 - 2 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 2/3/2022 - 2 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/2/2022 - 2 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 8/18/2021 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 5/25/2021 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP